Equitable Access and Neglected Disease Licensing
"“Equitable Access” and “Neglected Disease” licensing are twin elements of an open source-inspired proposal for improving access to essential medicines, put forward by Amy Kapczynski and colleagues at Yale University.
These licensing models explicitly envisage universities as licensors but could be adopted, for example, by other researchers and institutions operating within the TDI framework described above.
Equitable Access licensing aims to improve access to biomedical innovations in low-and middle-income countries. Neglected Disease licensing aims to facilitate research on orphan or neglected diseases." (http://opensourcebiotech.anu.edu.au/Open_Source_Biotechnology/Practice.html)